Correlation Between Blueprint Medicines and Phathom Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Blueprint Medicines and Phathom Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Blueprint Medicines and Phathom Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Blueprint Medicines Corp and Phathom Pharmaceuticals, you can compare the effects of market volatilities on Blueprint Medicines and Phathom Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Blueprint Medicines with a short position of Phathom Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Blueprint Medicines and Phathom Pharmaceuticals.
Diversification Opportunities for Blueprint Medicines and Phathom Pharmaceuticals
-0.36 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Blueprint and Phathom is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Blueprint Medicines Corp and Phathom Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Phathom Pharmaceuticals and Blueprint Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Blueprint Medicines Corp are associated (or correlated) with Phathom Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Phathom Pharmaceuticals has no effect on the direction of Blueprint Medicines i.e., Blueprint Medicines and Phathom Pharmaceuticals go up and down completely randomly.
Pair Corralation between Blueprint Medicines and Phathom Pharmaceuticals
Given the investment horizon of 90 days Blueprint Medicines Corp is expected to generate 0.44 times more return on investment than Phathom Pharmaceuticals. However, Blueprint Medicines Corp is 2.29 times less risky than Phathom Pharmaceuticals. It trades about 0.02 of its potential returns per unit of risk. Phathom Pharmaceuticals is currently generating about -0.12 per unit of risk. If you would invest 9,275 in Blueprint Medicines Corp on August 28, 2024 and sell it today you would earn a total of 112.00 from holding Blueprint Medicines Corp or generate 1.21% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Blueprint Medicines Corp vs. Phathom Pharmaceuticals
Performance |
| Timeline |
| Blueprint Medicines Corp |
| Phathom Pharmaceuticals |
Blueprint Medicines and Phathom Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Blueprint Medicines and Phathom Pharmaceuticals
The main advantage of trading using opposite Blueprint Medicines and Phathom Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Blueprint Medicines position performs unexpectedly, Phathom Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phathom Pharmaceuticals will offset losses from the drop in Phathom Pharmaceuticals' long position.| Blueprint Medicines vs. Eliem Therapeutics | Blueprint Medicines vs. HCW Biologics | Blueprint Medicines vs. Scpharmaceuticals | Blueprint Medicines vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |